Virtual Library
Start Your Search
Natasha Leighl
Moderator of
-
+
Mesothelin-Targeting Agents (ID 10)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 9
- Moderators:Anna Nowak, Natasha Leighl
- Coordinates: 7/11/2019, 16:25 - 17:15, Westin New York at Times Square
-
+
Amatuximab (ID 67)
16:25 - 17:15 | Author(s): Hedy Lee Kindler
- Abstract
Abstract not provided
-
+
Anetumab Ravtansine (ID 69)
16:25 - 17:15 | Author(s): Hedy Lee Kindler
- Abstract
Abstract not provided
-
+
ARTEMIS (Chemo-Amatuximab) (ID 68)
16:25 - 17:15 | Author(s): Hedy Lee Kindler
- Abstract
Abstract not provided
-
+
BMS-986148 (ADC) (ID 74)
16:25 - 17:15 | Author(s): Aaron Mansfield
- Abstract
Abstract not provided
-
+
CRS207 + Chemotherapy (ID 71)
16:25 - 17:15 | Author(s): Antoinette Wozniak
- Abstract
Abstract not provided
-
+
Listeria Mesothelin Vaccine CRS-207 (ID 70)
16:25 - 17:15 | Author(s): Matthew Gubens
- Abstract
Abstract not provided
-
+
LMB-100 (ID 73)
16:25 - 17:15 | Author(s): Raffit Hassan
- Abstract
Abstract not provided
-
+
Science (ID 66)
16:25 - 17:15 | Author(s): Raffit Hassan
- Abstract
Abstract not provided
-
+
SS1P (ID 72)
16:25 - 17:15 | Author(s): Giovanni Luca Ceresoli
- Abstract
Abstract not provided
Author of
-
+
Immune Checkpoint Inhibitors + Chemo or Other Immune Combination Co-Stimulatory and Co-Inhibitor Molecules (ID 14)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Dean Fennell, Anne Tsao
- Coordinates: 7/12/2019, 10:15 - 11:40, Westin New York at Times Square
-
+
Pembrolizumab + Chemo (Canada) (ID 101)
10:15 - 11:40 | Author(s): Natasha Leighl
- Abstract
Abstract not provided